annual cash & cash equivalents:
$120.26M+$10.29M(+9.36%)Summary
- As of today (July 1, 2025), KYMR annual cash & cash equivalents is $120.26 million, with the most recent change of +$10.29 million (+9.36%) on December 31, 2024.
- During the last 3 years, KYMR annual cash & cash equivalents has risen by +$72.28 million (+150.66%).
- KYMR annual cash & cash equivalents is now at all-time high.
Performance
KYMR Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$89.97M-$30.29M(-25.19%)Summary
- As of today (July 1, 2025), KYMR quarterly cash & cash equivalents is $89.97 million, with the most recent change of -$30.29 million (-25.19%) on March 31, 2025.
- Over the past year, KYMR quarterly cash & cash equivalents has dropped by -$3.54 million (-3.79%).
- KYMR quarterly cash & cash equivalents is now -42.63% below its all-time high of $156.82 million, reached on September 30, 2021.
Performance
KYMR quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KYMR Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +9.4% | -3.8% |
3 y3 years | +150.7% | +166.7% |
5 y5 years | +58.2% | - |
KYMR Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +150.7% | -42.2% | +79.4% |
5 y | 5-year | at high | +287.9% | -42.6% | +190.2% |
alltime | all time | at high | +287.9% | -42.6% | +190.2% |
KYMR Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $89.97M(-25.2%) |
Dec 2024 | $120.26M(+9.4%) | $120.26M(+8.6%) |
Sep 2024 | - | $110.72M(+63.8%) |
Jun 2024 | - | $67.61M(-27.7%) |
Mar 2024 | - | $93.51M(-15.0%) |
Dec 2023 | $109.97M(+60.8%) | $109.97M(+35.7%) |
Sep 2023 | - | $81.05M(+54.7%) |
Jun 2023 | - | $52.39M(+4.5%) |
Mar 2023 | - | $50.15M(-26.7%) |
Dec 2022 | $68.39M | $68.39M(-56.1%) |
Sep 2022 | - | $155.66M(+102.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $76.91M(+128.0%) |
Mar 2022 | - | $33.73M(-29.7%) |
Dec 2021 | $47.98M(+54.7%) | $47.98M(-69.4%) |
Sep 2021 | - | $156.82M(+84.7%) |
Jun 2021 | - | $84.90M(+59.9%) |
Mar 2021 | - | $53.10M(+71.3%) |
Dec 2020 | $31.00M(-59.2%) | $31.00M(-43.2%) |
Sep 2020 | - | $54.59M(-10.5%) |
Jun 2020 | - | $60.97M(-19.8%) |
Dec 2019 | $76.02M(+84.2%) | $76.02M |
Dec 2018 | $41.26M | - |
FAQ
- What is Kymera Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kymera Therapeutics?
- What is Kymera Therapeutics annual cash & cash equivalents year-on-year change?
- What is Kymera Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Kymera Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of KYMR is $120.26M
What is the all time high annual cash & cash equivalents for Kymera Therapeutics?
Kymera Therapeutics all-time high annual cash & cash equivalents is $120.26M
What is Kymera Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, KYMR annual cash & cash equivalents has changed by +$10.29M (+9.36%)
What is Kymera Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of KYMR is $89.97M
What is the all time high quarterly cash & cash equivalents for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly cash & cash equivalents is $156.82M
What is Kymera Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, KYMR quarterly cash & cash equivalents has changed by -$3.54M (-3.79%)